Recombinant Herpetosiphon aurantiacus ATP synthase subunit alpha (AtpA), partial, refers to a genetically engineered protein fragment derived from the α-subunit of the ATP synthase complex in the gliding bacterium Herpetosiphon aurantiacus. ATP synthase is a critical enzyme in cellular energy metabolism, catalyzing ATP synthesis via oxidative phosphorylation. The α-subunit forms part of the catalytic F1 domain, essential for ATP hydrolysis and synthesis. This recombinant variant is produced for structural, functional, and biomedical research applications.
Partial Sequence: While full-length AtpA sequences typically span ~550 residues, the recombinant "partial" variant may exclude non-essential regions. For example, H. aurantiacus ATP synthase β-subunit (AtpD) shares operon organization with AtpA, suggesting structural coordination .
Critical Motifs: The α-subunit contains nucleotide-binding domains (e.g., Walker A/B motifs) and residues critical for ATPase activity, as observed in homologous bacterial systems .
H. aurantiacus ATP synthase operates within a functional poly(ADP-ribose) (PAR) metabolic pathway:
PARP Activity: H. aurantiacus PARP synthesizes PAR polymers, while its PARG enzyme hydrolyzes them .
ATP Synthase Interplay: ATP synthase activity may regulate PAR-mediated signaling, though direct links require further study .
| Region | Sequence (Partial) | Functional Role |
|---|---|---|
| N-terminal | MATGKILQIT GVVIDAEFPA DGLPQIYNAL EIPLGEGRSS | Nucleotide binding |
| Central | LICEVQQQLG DSVVRAVAMS TTDGLVRGMD VIDTGAPISV | Catalytic coordination |
| C-terminal | EGAVGTTKTM PIHRPAPTFE EQSNRAELFE TGIKVIDLIA | Subunit interaction |
Antimicrobial Targets: ATP synthase subunits are explored as drug targets due to their essential role in bacterial energetics .
Enzyme Engineering: Recombinant AtpA facilitates studies on ATP synthase mechanics and evolution, particularly in understudied bacteria like H. aurantiacus .
KEGG: hau:Haur_4070
STRING: 316274.Haur_4070
Expressing recombinant H. aurantiacus atpA typically follows standard recombinant protein expression protocols with specific considerations for this protein. Based on approaches used for other ATP synthase subunits, the following methodology is recommended:
Gene Cloning:
Amplify the atpA gene from H. aurantiacus genomic DNA using PCR with specific primers designed to include appropriate restriction sites
Clone the amplified gene into an expression vector (e.g., pET series for E. coli expression)
Verify the sequence to ensure no mutations were introduced during PCR
Expression System Selection:
E. coli BL21(DE3) or similar strains are commonly used for recombinant ATP synthase subunit expression
Consider using specialized strains for membrane proteins if working with the full-length atpA
Expression Conditions:
Induce expression with IPTG (0.1-1.0 mM) when cultures reach mid-log phase
Lower temperatures (16-25°C) often yield better results for ATP synthase subunits
Extended expression times (12-24 hours) may be necessary for optimal yields
Protein Purification:
Similar approaches have been successfully used for ATP synthase subunits from other organisms, as evidenced by studies where the atpA ORF was fused to GFP for localization and interaction studies .
Purification of recombinant atpA presents several challenges that researchers should anticipate:
Proteolytic Degradation:
ATP synthase subunits are susceptible to proteolysis during purification
Evidence from studies on ValRS-ATP synthase interactions showed numerous bands corresponding to putative proteolytic products despite measures taken to avoid proteolysis
Solution: Use freshly prepared buffers with a cocktail of protease inhibitors, maintain cold temperatures throughout the purification process, and consider adding reducing agents
Solubility Issues:
As a component of a membrane-associated complex, atpA may have hydrophobic regions that affect solubility
Solution: Optimize buffer conditions with appropriate detergents (e.g., DDM, CHAPS) or consider extracting the protein under native conditions that preserve its natural conformation
Maintaining Functional Conformation:
The alpha subunit's functionality depends on proper folding
Solution: Avoid harsh purification conditions that might denature the protein; consider purifying under non-denaturing conditions
Co-purifying Contaminants:
ATP synthase subunits often co-purify with other components of the complex or abundant cellular proteins
Studies have shown that RuBisCO is a frequent contaminant in ATP synthase purifications
Solution: Implement multiple purification steps (e.g., ion exchange after affinity chromatography) and validate protein purity through methods like mass spectrometry
Low Yield:
Expression levels of functional recombinant ATP synthase subunits can be low
Solution: Optimize codon usage for the expression system, test different fusion tags, and screen multiple expression conditions to maximize yield
Verifying the identity and purity of recombinant H. aurantiacus atpA should involve multiple complementary analytical techniques:
Mass Spectrometry Analysis:
Western Blotting:
Use antibodies specific to atpA or to affinity tags if present
Compare migration pattern with expected molecular weight
Assess the presence of degradation products or contaminating proteins
Activity Assays:
While the isolated alpha subunit may not show ATP synthesis activity, ATPase activity can sometimes be measured
Binding assays with other ATP synthase subunits can confirm proper folding and function
Circular Dichroism (CD) Spectroscopy:
Assess secondary structure content to verify proper folding
Compare with CD spectra of ATP synthase alpha subunits from related organisms
Size Exclusion Chromatography:
Analyze oligomeric state and homogeneity of the purified protein
Detect potential aggregation or complex formation
Protein Purity Assessment:
SDS-PAGE with Coomassie or silver staining to evaluate purity
Densitometric analysis to quantify purity percentage
Consider 2D gel electrophoresis for more detailed purity assessment
Investigating protein-protein interactions of H. aurantiacus atpA requires sophisticated approaches that can capture both stable and transient interactions:
GFP Fusion Pull-down Assays:
Creating atpA-GFP fusion constructs has proven effective for studying ATP synthase interactions
This approach successfully identified interactions between ValRS and ATP synthase in Anabaena
The method involves:
a) Generating an atpA-GFP fusion construct
b) Expressing the fusion protein in the appropriate system
c) Performing pull-down assays with anti-GFP antibodies
d) Analyzing co-purifying proteins by mass spectrometry
In vivo Crosslinking:
Crosslinking studies have successfully demonstrated interactions between ATP synthase subunits and other proteins
In Anabaena, cultures expressing AtpA-GFP were subjected to in vivo crosslinking followed by purification with anti-GFP antibodies coupled to magnetic beads
This approach can capture transient or weak interactions that might be lost during conventional purification
Clear Native PAGE (CN-PAGE):
CN-PAGE has been used to detect ATP synthase complexes and their interactions with other proteins
In previous studies, ATP synthase subunits were observed in two distinct complexes in CN-PAGE, with the high molecular weight complex depending on the presence of interaction partners
This technique preserves native protein-protein interactions and complex integrity
Yeast Two-Hybrid or Bacterial Two-Hybrid Systems:
These systems can screen for potential interaction partners
Consider using domain-specific constructs if the full-length protein proves challenging
Surface Plasmon Resonance (SPR) or Bio-Layer Interferometry (BLI):
These techniques provide quantitative measurements of binding kinetics
Immobilize purified recombinant atpA on a sensor chip and flow potential binding partners over the surface
| Technique | Advantages | Limitations | Sample Requirements |
|---|---|---|---|
| GFP Fusion Pull-down | Works in native cellular context; Can identify unknown partners | May affect protein function; Background binding | Expression system for fusion protein |
| In vivo Crosslinking | Captures transient interactions; Preserves cellular context | May crosslink non-specific proteins; Complex analysis | Living cells expressing target protein |
| CN-PAGE | Preserves native complexes; Good for membrane proteins | Limited to stable complexes; Lower resolution than SDS-PAGE | Purified complexes or membrane fractions |
| Two-Hybrid Systems | High-throughput screening; Works for weak interactions | High false positive/negative rate; Artificial environment | cDNA library or candidate interactors |
| SPR/BLI | Quantitative kinetic data; Real-time measurements | Requires purified proteins; Surface immobilization may affect binding | Highly purified proteins |
Assessing the enzymatic activity of recombinant atpA requires different approaches depending on whether you're working with the isolated subunit or attempting to reconstitute functional complexes:
Isolated Alpha Subunit Activity:
ATP Binding Assays:
Use fluorescent ATP analogs to measure binding affinity
Isothermal titration calorimetry (ITC) for binding thermodynamics
Limited ATPase Activity:
While the alpha subunit alone typically shows minimal ATPase activity, sensitive assays can detect basal activity
Use a coupled enzyme assay system (with pyruvate kinase and lactate dehydrogenase) to detect ATP hydrolysis by monitoring NADH oxidation
Reconstituted Complex Activity:
Complex Assembly:
Combine purified alpha subunit with other essential components (β, γ, etc.)
Verify complex formation by native gel electrophoresis or size exclusion chromatography
ATP Synthesis Activity:
Create proteoliposomes with the reconstituted complex
Generate a proton gradient (pH jump or valinomycin-induced K+ diffusion potential)
Measure ATP production using luciferase-based assays
Functional Complementation:
Express H. aurantiacus atpA in ATP synthase-deficient bacterial strains
Assess restoration of growth under conditions requiring ATP synthase function
Compare complementation efficiency with atpA from other species
Inhibitor Studies:
Test sensitivity to known ATP synthase inhibitors
Resveratrol has been shown to bind to the ATP synthase in the F₁-domain and partially inhibit both ATP hydrolysis and ATP synthesis
Oligomycin A can be used as a reference inhibitor, though it has similar IC₅₀ values for bacterial and human mitochondrial ATP synthases
Mutational Analysis:
Create targeted mutations in conserved catalytic residues
Analyze the effects on ATP binding and hydrolysis
Compare with equivalent mutations in well-characterized ATP synthase systems
| Activity Assay | Measurement Principle | Detection Method | Sensitivity | Special Considerations |
|---|---|---|---|---|
| ATP Binding | Direct binding of ATP or analogs | Fluorescence anisotropy, ITC | High | Distinguishes binding from hydrolysis |
| ATP Hydrolysis | Release of inorganic phosphate | Malachite green, molybdate | Moderate | Can detect activity of isolated subunit |
| Coupled Enzyme | NADH oxidation coupled to ATP hydrolysis | Spectrophotometric (340 nm) | High | Continuous real-time measurements |
| ATP Synthesis | ATP production from ADP and Pi | Luciferase luminescence | Very high | Requires reconstituted system with proton gradient |
Optimizing expression and purification of functional recombinant H. aurantiacus atpA requires careful consideration of multiple factors:
Expression System Selection:
E. coli BL21(DE3) remains the most common system for recombinant ATP synthase subunit expression
Consider C41(DE3) or C43(DE3) strains specifically designed for membrane protein expression
For challenging expressions, alternative systems such as Bacillus subtilis or cell-free expression systems may be evaluated
Vector and Fusion Tag Optimization:
Expression Condition Optimization:
Temperature: Lower temperatures (16-20°C) often yield more properly folded protein
Inducer concentration: Typical IPTG concentrations range from 0.1-0.5 mM, but lower concentrations may improve folding
Media composition: Enriched media (TB, 2YT) typically yield higher biomass but defined minimal media may improve folding
Test expression matrix:
| Temperature | IPTG Concentration | Induction Time | Media Type |
|---|---|---|---|
| 16°C | 0.1 mM | 16-24 hours | TB |
| 25°C | 0.25 mM | 6-8 hours | 2YT |
| 30°C | 0.5 mM | 3-4 hours | LB |
| 37°C | 1.0 mM | 2-3 hours | M9 |
Purification Buffer Optimization:
pH range: Typically 7.0-8.0 for ATP synthase subunits
Salt concentration: 150-300 mM NaCl is standard, but higher concentrations may improve stability
Additives to consider:
5-10% glycerol to prevent aggregation
1-5 mM MgCl₂ (important for nucleotide binding proteins)
ATP or non-hydrolyzable ATP analogs (0.1-1 mM) to stabilize conformation
Reducing agents (1-5 mM DTT or 0.5-2 mM TCEP)
Multi-step Purification Strategy:
Initial capture: Affinity chromatography based on fusion tag (IMAC for His-tag, etc.)
Intermediate purification: Ion exchange chromatography to remove similarly charged contaminants
Polishing: Size exclusion chromatography to separate oligomeric states and remove aggregates
Consider specific precautions to avoid proteolysis, which has been observed during purification of ATP synthase components
Quality Control Checkpoints:
After each purification step, assess:
Purity by SDS-PAGE
Identity by Western blot or mass spectrometry
Oligomeric state by native PAGE or size exclusion chromatography
Activity using appropriate functional assays
While the search results don't specifically address therapeutic applications of H. aurantiacus atpA, research on ATP synthase from other organisms provides a framework for such investigations:
Antimicrobial Development Based on ATP Synthase Inhibition:
ATP synthase inhibition sensitizes S. aureus to antimicrobial peptides and neutrophil killing
Design experiments to test if:
H. aurantiacus atpA can complement ATP synthase function in pathogenic bacteria
Structural differences between H. aurantiacus atpA and human ATP synthase could be exploited for selective inhibitor design
Recombinant H. aurantiacus atpA can be used in high-throughput screening for novel inhibitors
Cancer Research Applications:
ATP synthase α-subunit has been identified as a potential therapeutic target for breast cancer
Expression is upregulated in highly metastatic cells compared to low metastatic cells
Studies have shown ATP synthase α-subunit expression in 94.6% of breast cancer specimens compared to only 21.2% in normal breast tissues
Using recombinant H. aurantiacus atpA, researchers could:
Develop molecular probes to study ATP synthase structure and function
Create tools for comparative studies between bacterial and human ATP synthases
Identify structural elements that could inform development of selective inhibitors
Experimental Design for Therapeutic Targeting:
Structure-Based Drug Design:
Use recombinant H. aurantiacus atpA to generate structural data
Perform in silico screening for potential binding molecules
Verify binding with biophysical techniques (SPR, ITC, etc.)
Functional Screening:
Develop high-throughput assays using recombinant protein
Screen compound libraries for inhibitors or modulators
Validate hits with secondary assays and selectivity testing
Antibody Development:
Generate antibodies against recombinant H. aurantiacus atpA
Test cross-reactivity with human ATP synthase
Evaluate potential for diagnostic or therapeutic applications
Previous studies have shown antibodies against ATP synthase α-subunit can inhibit proliferation, migration and invasion in breast cancer cells
Host-Pathogen Interaction Studies:
Investigate if H. aurantiacus atpA or its derivatives interact with human immune components
Test if structural elements from bacterial ATP synthase could be used to enhance AMP activity
Develop peptide mimetics based on bacterial ATP synthase structure that could potentiate antimicrobial activity
| Therapeutic Approach | Potential Advantage | Research Model | Key Methodology |
|---|---|---|---|
| ATP synthase inhibitors | Sensitization to endogenous AMPs | Bacterial infection models | Compound screening, time-kill assays |
| Structure-based drug design | Selective targeting | Computer modeling, in vitro binding | X-ray crystallography, molecular docking |
| Antibody-based therapies | Specificity to cancer cells | Cancer cell lines, xenograft models | Monoclonal antibody development, ADCC assays |
| Peptide mimetics | Novel mechanism of action | In vitro AMP activity | Peptide synthesis, membrane disruption assays |
Advanced imaging techniques are essential for understanding the localization and dynamics of ATP synthase components in bacterial cells:
Fluorescent Protein Fusion Microscopy:
GFP-tagged ATP synthase subunits have been successfully used to study localization patterns
In Anabaena, AtpA-GFP showed thylakoidal localization in vegetative cells and enrichment at the cell poles in heterocysts
Methodology:
Create C-terminal or N-terminal GFP fusions of atpA
Express in appropriate bacterial system
Image using confocal or wide-field fluorescence microscopy
For optimal results, use photo-stable GFP variants (e.g., mNeonGreen, mEGFP)
Super-Resolution Microscopy:
Techniques like STORM, PALM, or STED provide nanoscale resolution beyond the diffraction limit
These approaches can resolve individual ATP synthase complexes and their organization
Implementation:
Use photoactivatable or photoswitchable fluorophores for PALM/STORM
Optimize sample preparation to minimize background fluorescence
Consider dual-color imaging to study co-localization with other proteins
Single-Particle Tracking:
Tracks the movement of individual ATP synthase complexes in live cells
Reveals dynamics, diffusion rates, and potential confinement zones
Approach:
Use photoactivatable fluorophores or quantum dots for labeling
Acquire time-lapse images at high frame rates
Analyze trajectories to determine diffusion coefficients and confinement
Fluorescence Recovery After Photobleaching (FRAP):
Measures protein mobility within membranes
Can reveal if ATP synthase complexes are freely diffusing or restricted
Protocol:
Express atpA-GFP fusion in bacteria
Photobleach a defined region of interest
Monitor fluorescence recovery over time
Calculate diffusion coefficients from recovery curves
Förster Resonance Energy Transfer (FRET):
Detects interactions between ATP synthase subunits or with other proteins
Provides information on conformational changes during function
Implementation:
Create donor-acceptor fluorophore pairs on different components
Measure energy transfer efficiency
Correlate with functional states of the enzyme
Cryo-Electron Tomography:
Visualizes ATP synthase complexes in their native cellular environment
Provides structural information in the cellular context
Approach:
Vitrify bacterial cells expressing tagged atpA
Collect tilt series for tomographic reconstruction
Identify ATP synthase complexes through sub-tomogram averaging
| Imaging Technique | Resolution | Live/Fixed Cells | Information Provided | Key Limitations |
|---|---|---|---|---|
| Confocal Microscopy with GFP Fusion | ~200-300 nm | Both | General localization, expression levels | Diffraction-limited resolution |
| STORM/PALM | 10-30 nm | Usually fixed | Precise localization, clustering analysis | Long acquisition times, phototoxicity |
| Single-Particle Tracking | 10-50 nm | Live | Dynamics, diffusion coefficients | Technically challenging, limited time window |
| FRAP | ~1 μm (region) | Live | Mobility, diffusion constraints | Low spatial resolution |
| FRET | 1-10 nm | Both | Protein-protein interactions, conformational changes | Complex setup, careful controls needed |
| Cryo-ET | 3-5 nm | Fixed (vitrified) | Native structure in cellular context | Complex sample preparation, specialized equipment |
Characterizing interactions between H. aurantiacus atpA and potential inhibitors requires a systematic approach combining biophysical, structural, and functional techniques:
Binding Affinity and Kinetics Determination:
Surface Plasmon Resonance (SPR):
Immobilize purified recombinant atpA on a sensor chip
Flow inhibitor solutions at varying concentrations
Calculate association (k₁) and dissociation (k₋₁) rate constants
Determine equilibrium dissociation constant (KD)
Isothermal Titration Calorimetry (ITC):
Measures binding thermodynamics (ΔH, ΔS, ΔG)
Provides stoichiometry of binding
Works with inhibitors of diverse solubility properties
Microscale Thermophoresis (MST):
Requires small amounts of protein
Works well for membrane proteins and challenging targets
Detects binding in near-native conditions
Structural Characterization of Binding:
X-ray Crystallography:
Co-crystallize atpA with inhibitors to determine binding site
Provides atomic-level details of interaction interfaces
Identifies key residues involved in binding
Nuclear Magnetic Resonance (NMR):
Chemical shift perturbation to map binding interface
Dynamics of protein-inhibitor complex
Works well for weak or transient interactions
Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS):
Maps regions protected from exchange upon inhibitor binding
Does not require crystallization
Provides information on conformational changes
Functional Impact Assessment:
Enzyme Activity Assays:
Measure IC₅₀ and Ki values using ATP hydrolysis assays
Determine mechanism of inhibition (competitive, non-competitive, uncompetitive)
Assess reversibility of inhibition
Thermal Shift Assays:
Monitor protein stability changes upon inhibitor binding
High-throughput screening capability
Can provide indirect evidence of binding
Comparative Studies with Known Inhibitors:
Resveratrol binds to the F₁-domain of ATP synthase and partially inhibits both ATP hydrolysis and ATP synthesis
Oligomycin A is a reference inhibitor but has similar IC₅₀ values between bacterial and human mitochondrial ATP synthases
Structure-activity relationship studies comparing novel compounds with established inhibitors
Selectivity Profiling:
Counter-screening against human ATP synthase
Testing against panel of other nucleotide-binding proteins
Assessing off-target effects in cellular systems
| Technique | Information Provided | Sample Requirements | Throughput | Key Advantages |
|---|---|---|---|---|
| SPR | K₁, k₋₁, KD | Low μg of immobilized protein | Medium | Real-time kinetics, no labeling needed |
| ITC | KD, ΔH, ΔS, n | 0.1-1 mg protein | Low | Complete thermodynamic profile |
| MST | KD | Low μg protein, fluorescently labeled | Medium-High | Works with membrane proteins, low sample consumption |
| X-ray Crystallography | Atomic resolution structure | mg quantities, crystallizable protein | Very Low | Highest resolution structural details |
| HDX-MS | Binding regions, conformational changes | 10-100 μg protein | Low-Medium | No size limitation, works with membrane proteins |
| Thermal Shift | Stabilization effect | 1-10 μg protein | High | Amenable to high-throughput screening |
| Enzyme Inhibition | IC₅₀, Ki, mechanism | Active protein preparation | Medium-High | Direct functional relevance |
When encountering contradictory results in atpA research across different experimental systems, a systematic approach to data interpretation is essential:
Experimental System Differences Assessment:
Expression System Variables:
Assay Condition Variations:
Buffer components, pH, ionic strength, and temperature can significantly impact protein function
ATP synthase activity is particularly sensitive to membrane environment and proton gradient
Inhibitor effectiveness may vary with experimental conditions (e.g., resveratrol's inhibition of ATP synthase depends on specific binding conditions)
Protein Construct Considerations:
Fusion Tags Impact:
Truncation Effects:
Physiological Context Differences:
In Vivo vs. In Vitro Discrepancies:
Cell Type-Specific Effects:
Systematic Troubleshooting Approach:
Control Experiment Matrix:
Design experiments with positive and negative controls for each variable
Include system-specific controls to validate assay performance
Parameter Isolation:
Systematically vary one parameter at a time to identify critical variables
Test protein activity across a range of conditions to establish optimal parameters
Data Integration Framework:
Develop a model that accommodates apparently contradictory results
Consider that different experimental systems may reveal different aspects of atpA function
| Source of Contradiction | Troubleshooting Approach | Control Experiment | Resolution Strategy |
|---|---|---|---|
| Expression system differences | Express protein in multiple systems | Compare with native protein from original organism | Identify system-specific modifications or folding issues |
| Fusion tag effects | Test multiple tag positions and types | Include tag-free protein control | Use cleavable tags and compare pre/post-cleavage activity |
| Buffer/assay conditions | Systematic buffer screening | Include known active protein control | Establish condition-dependent activity profiles |
| Protein-protein interactions | Pull-down with vs. without crosslinking | Test with known interacting partners | Map interaction dependencies on experimental conditions |
| In vivo vs. in vitro | Parallel cell-based and purified protein assays | Use genetic complementation controls | Identify missing cofactors or cellular components |
Ensuring reliable results with recombinant H. aurantiacus atpA requires rigorous quality control at multiple stages of the experimental workflow:
Gene and Construct Verification:
Sequence Confirmation:
Complete DNA sequencing of the expression construct
Verification of reading frame and absence of mutations
Confirmation of regulatory elements and fusion tag sequences
Expression Vector Stability:
Plasmid stability testing in the expression host
Verification of selection marker functionality
Assessment of copy number consistency
Protein Expression Quality Control:
Expression Level Monitoring:
Time-course analysis of expression
Comparison of soluble versus insoluble fractions
Optimization of induction conditions to maximize functional protein
Protein Solubility Assessment:
Differentiate between truly soluble protein and solubilized aggregates
Analyze oligomeric state by native PAGE or size exclusion chromatography
ATP synthase subunits can form aggregates or incorrect assemblies if expression conditions are suboptimal
Purification Quality Metrics:
Purity Assessment:
Integrity Verification:
Homogeneity Evaluation:
Dynamic light scattering to assess polydispersity
Analytical ultracentrifugation for detailed characterization
Size exclusion chromatography to detect aggregates
Functional Validation:
Activity Benchmarking:
Comparison with established standards or reference preparations
Dose-response relationships with known activators/inhibitors
ATP synthase activity can be measured through ATP synthesis/hydrolysis assays
Binding Properties:
Verification of nucleotide binding
Assessment of interaction with other ATP synthase subunits
Confirmation of inhibitor binding if relevant
Stability Monitoring:
Storage Stability:
Activity retention during storage at different temperatures
Monitoring of degradation or aggregation over time
Optimization of buffer conditions for long-term stability
Freeze-Thaw Stability:
Quantification of activity loss after freeze-thaw cycles
Development of aliquoting strategy to minimize freeze-thaw events
Assessment of cryoprotectant effectiveness
| Quality Control Checkpoint | Method | Acceptance Criteria | Troubleshooting if Failed |
|---|---|---|---|
| DNA Construct Integrity | Sequencing, restriction analysis | 100% sequence match, correct restriction pattern | Reclone from verified template |
| Expression Level | SDS-PAGE, Western blot | Visible band of expected size, ≥0.1 mg/L culture | Optimize expression conditions, consider different host |
| Protein Solubility | Supernatant/pellet analysis after centrifugation | ≥50% of expressed protein in soluble fraction | Adjust lysis conditions, expression temperature |
| Purity | SDS-PAGE, HPLC | ≥90% pure by densitometry or HPLC | Add purification steps, optimize existing protocols |
| Homogeneity | SEC, DLS | Single peak in SEC, PDI <0.2 in DLS | Optimize buffer conditions, add polishing steps |
| Functional Activity | Enzyme activity assay | Activity within 20% of reference standard | Check for inhibitors in buffer, verify protein integrity |
| Stability | Activity retention over time | ≥80% activity after 1 week at 4°C | Add stabilizers, optimize storage conditions |
Several cutting-edge technologies are poised to revolutionize our understanding of ATP synthase subunit structure-function relationships:
Cryo-Electron Microscopy (Cryo-EM) Advancements:
Single-particle cryo-EM now routinely achieves near-atomic resolution
Capable of resolving conformational heterogeneity in complex systems
Can capture different functional states of ATP synthase
Application to H. aurantiacus atpA:
Determine structure in different nucleotide-bound states
Visualize interactions with other ATP synthase subunits
Identify conformational changes during catalytic cycle
Integrative Structural Biology Approaches:
Combining multiple structural techniques:
X-ray crystallography for high-resolution static structures
Cryo-EM for conformational ensembles
NMR for dynamics information
SAXS for solution conformation
Computational integration of diverse structural data
Benefits for atpA research:
Comprehensive view of structure-function relationships
Identification of allosteric networks
Improved models for inhibitor design
Single-Molecule Techniques:
Single-molecule FRET:
Monitors conformational dynamics in real-time
Can observe rare or transient states
Correlates structural changes with function
Magnetic tweezers or optical traps:
Measure mechanical forces during ATP synthase operation
Directly observe rotational movements
Application to atpA research:
Monitor conformational changes during catalysis
Correlate ATP binding/hydrolysis with structural transitions
Investigate effects of inhibitors on molecular dynamics
Advanced Computational Methods:
Molecular Dynamics Simulations:
Atomistic simulations now reaching millisecond timescales
Enhanced sampling techniques for rare event observation
Integration with experimental data via hybrid approaches
Machine Learning Applications:
Prediction of protein-protein interaction interfaces
Virtual screening for novel inhibitors
Extraction of patterns from large experimental datasets
Benefits for H. aurantiacus atpA:
Prediction of functional effects of mutations
Design of improved inhibitors
Understanding species-specific functional differences
In-cell Structural Biology:
Cryo-electron tomography of intact cells
In-cell NMR spectroscopy
Proximity labeling methods (APEX, BioID)
Application to ATP synthase research:
Visualization of ATP synthase in native membrane environment
Mapping of protein-protein interactions in cellular context
Understanding of spatial organization and dynamics in vivo
Synthetic Biology and Protein Engineering:
Creation of minimal functional units
Domain swapping between species
Incorporation of non-canonical amino acids for site-specific probes
Potential for atpA research:
Engineering chimeric proteins to identify functional domains
Introduction of biophysical probes at specific sites
Creation of optogenetically controlled variants
| Technology | Key Advantage | Application to atpA Research | Technical Challenges |
|---|---|---|---|
| Cryo-EM | High-resolution structures without crystallization | Whole ATP synthase complex structure determination | Sample preparation, conformational heterogeneity |
| Single-molecule FRET | Real-time observation of conformational dynamics | Monitoring catalytic cycle conformational changes | Specific labeling, signal-to-noise ratio |
| MD Simulations | Atomic-level dynamics at biologically relevant timescales | Mechanism of ATP binding and hydrolysis | Computational cost, force field accuracy |
| In-cell Structural Biology | Native cellular context | Organization of ATP synthase in bacterial membranes | Resolution limitations, cellular heterogeneity |
| Protein Engineering | Precise control of protein structure | Structure-function mapping through targeted modifications | Maintaining protein stability and function |
Comparative studies of H. aurantiacus atpA can provide valuable insights into ATP synthase evolution and specialization:
Evolutionary Conservation and Divergence:
Sequence and Structural Homology Analysis:
Alignment of atpA sequences across diverse species
Identification of universally conserved versus lineage-specific features
Structure-based alignments to identify functional conservation despite sequence divergence
Phylogenetic Analysis:
Construction of robust phylogenetic trees
Correlation of ATP synthase evolution with ecological niches
Identification of horizontal gene transfer events
Functional Adaptations in Different Environments:
Thermodynamic and Kinetic Adaptations:
Membrane Environment Adaptations:
Lipid interactions and requirements
Adaptation to different membrane compositions
Integration with other membrane protein complexes
Novel Functions and Moonlighting Roles:
Non-canonical Functions:
ATP synthase components have been identified as cell-surface receptors for apparently unrelated ligands
In breast cancer, ATP synthase α-subunit is detected on the cell surface and may be involved in cancer progression
In bacteria like S. aureus, ATP synthase affects tolerance to antimicrobial peptides
Species-Specific Interactions:
Structural Specializations:
Subunit Composition Variations:
Differences in subunit number and arrangement
Alternative isoforms in different species or tissues
Presence or absence of regulatory subunits
Catalytic Site Adaptations:
Variations in nucleotide binding affinity
Adaptations to different ATP/ADP ratios or pH environments
Species-specific inhibitor sensitivity
Research Approaches and Methodologies:
Comparative Biochemistry:
Side-by-side functional assays of atpA from different species
Reciprocal complementation experiments
Chimeric proteins with domains from different species
Structural Comparisons:
Superposition of ATP synthase structures from diverse species
Identification of conformational differences in equivalent functional states
Analysis of species-specific structural elements
Systems Biology Approaches:
Integration of atpA function with metabolic networks
Comparison of regulatory mechanisms across species
Modeling of ATP synthase contribution to cellular energetics in different organisms
| Evolutionary Aspect | Research Approach | Expected Insights | Implications |
|---|---|---|---|
| Sequence Conservation | Multiple sequence alignment, ConSurf analysis | Identification of functional motifs, variable regions | Target selection for inhibitor design |
| Structural Adaptations | Comparative structural analysis, homology modeling | Species-specific structural features | Understanding of specialized functions |
| Functional Divergence | Enzyme kinetics across species, substrate specificity | Adaptation to different metabolic demands | Insight into energy metabolism evolution |
| Interaction Networks | Interactome mapping in multiple species | Species-specific protein-protein interactions | Evolutionary context of molecular functions |
| Non-canonical Functions | Phenotypic analysis of atpA mutants | Moonlighting roles in different organisms | New therapeutic targets or biotechnological applications |